AILERON THERAPEUTICS INC Business Finance Contracts & Agreements
18 Contracts & Agreements
- Exchange Agreements (3 contracts)
- Investor Rights Agreements (1)
- Purchase Agreements (3)
- Registration Rights Agreements (3)
- Stock Agreements (2)
- Underwriting Agreements (2)
- Warrant Agreements (4)
- Form of Registration Rights Agreement, by and among Aileron Therapeutics, Inc. and certain purchasers named therein (Filed With SEC on October 31, 2023)
- Stock and Warrant Purchase Agreement, dated as of October 31, 2023, by and among Aileron Therapeutics, Inc. and each purchaser identified on Annex A thereto (Filed With SEC on October 31, 2023)
- Form of Warrant to Purchase Common Stock to be issued pursuant to the Stock and Warrant Purchase Agreement (Filed With SEC on October 31, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on January 7, 2021)
- Registration Rights Agreement, dated as of September 21, 2020, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on September 22, 2020)
- Purchase Agreement, dated as of September 21, 2020, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on September 22, 2020)
- Underwriting Agreement, dated June 4, 2020, by and between the Company and William Blair & Company, L.L.C (Filed With SEC on June 5, 2020)
- Registration Rights Agreement, dated March 28, 2019, by and among the Company and the persons party thereto (Filed With SEC on April 1, 2019)
- Form of Warrant to Purchase Common Stock to be issued pursuant to the Purchase Agreement (Filed With SEC on April 1, 2019)
- Form of Pre-Funded Warrant to Purchase Common Stock to be issued pursuant to the Purchase Agreement (Filed With SEC on April 1, 2019)
- Securities Purchase Agreement, dated March 28, 2019, by and among the Company and the persons party thereto (the Purchase Agreement) (Filed With SEC on April 1, 2019)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on June 19, 2017)
- AILERON THERAPEUTICS, INC. 2017EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 19, 2017)
- AILERON THERAPEUTICS, INC. NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on June 19, 2017)
- AILERON THERAPEUTICS, INC. (a Delaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 19, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on June 2, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on June 2, 2017)
- SEVENTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on June 2, 2017)